[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  aponia_analytics [@AponiaAnalytics](/creator/twitter/AponiaAnalytics) on x 4954 followers Created: 2025-07-20 16:04:00 UTC 🦉 In Cree’s PCOS trial, X of XX semaglutide-treated women didn’t lose ≥10% body weight. One lost none. Response variability mirrors obesity trial data—GLP-1s don’t work equally for all phenotypes. #GLP1 #PCOS $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY XX engagements  **Related Topics** [pfe](/topic/pfe) [manat](/topic/manat) [$rhhby](/topic/$rhhby) [$gsk](/topic/$gsk) [$sny](/topic/$sny) [$lly](/topic/$lly) [women](/topic/women) [$nvo](/topic/$nvo) [Post Link](https://x.com/AponiaAnalytics/status/1946964317863129280)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
aponia_analytics @AponiaAnalytics on x 4954 followers
Created: 2025-07-20 16:04:00 UTC
🦉 In Cree’s PCOS trial, X of XX semaglutide-treated women didn’t lose ≥10% body weight. One lost none. Response variability mirrors obesity trial data—GLP-1s don’t work equally for all phenotypes.
#GLP1 #PCOS $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY
XX engagements
/post/tweet::1946964317863129280